Single-Session Percutaneous Mechanical Thrombectomy Using the Aspirex®S Device Plus Stenting for Acute Iliofemoral Deep Vein Thrombosis: Safety, Efficacy, and Mid-Term Outcomes
Romaric Loffroy, Nicolas Falvo, Kévin Guillen et al. · Diagnostics · 2020
To assess the safety, efficacy and mid-term outcomes of single-session percutaneous mechanical thrombectomy (PMT) for acute symptomatic iliofemoral deep vein thrombosis (DVT) using the Aspirex®S device. Retrospective review of 30 patients (women, 23; mean age, 45.5 ± 19.9 years; range, 17–76) who underwent PMT with the 10-French Aspirex®S device (Straub Medical AG, Wangs, Switzerland) for acute DVT between December 2015 and March 2019. Procedures were performed by popliteal (n = 22) or jugular (n = 7) approach, or both (n = 1). Mean time from diagnosis to PMT was 5.5 ± 4.6 days (range, 2–11). Successful thrombus removal and venous patency restoration were achieved in all patients (100%). Fluid removal was 307.8 ± 66.1 mL (range, 190–410). Additional venous stenting rate was 100%. Mean procedural time was 107.3 ± 33.9 min (range, 70–180). No major complication occurred. The patient’s postprocedural course was uneventful in all cases, with hospital discharge within 2 days in 83.3%. Early in-stent rethrombosis occurred within 1 week in 3 patients, successfully managed by endovascular approach. Secondary stent patency rate was 86.7% at a mean follow-up of 22.3 ± 14.2 months (range, 6–48), as assessed by Duplex ultrasound. Single-session of PMT using the Aspirex®S device is a safe and effective therapeutic option in patients presenting with acute symptomatic iliofemoral DVT.
Cited by 24 works. doi:10.3390/diagnostics10080544 Open-access PDF
Authors
- Romaric Loffroy
- Nicolas Falvo
- Kévin Guillen
- Christophe Galland
- Xavier Baudot
- Emmanuel Demaistre
- Léo Fréchier
- Frédérik Ledan
- Marco Midulla
- Olivier Chevallier
References
- Antithrombotic Therapy for VTE Disease
- The Long-Term Clinical Course of Acute Deep Venous Thrombosis
- The Epidemiology of Venous Thromboembolism
- Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
- Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
- Endovascular Management of Iliac Vein Compression (May-Thurner) Syndrome
- Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization
- Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal
- Post‐thrombotic syndrome: prevalence, prognostication and need for progress
- SCVIR Reporting Standards for the Treatment of Acute Limb Ischemia with Use of Transluminal Removal of Arterial Thrombus